Display options
Cite
Boldt J, Wollbrück T, Sonneborn S, et al. Thrombomodulin in intensive care patients. Intensive Care Med. 1995;21(8):645-50doi: 10.1007/BF01711542.
Boldt, J., Wollbrück, T., Sonneborn, S., Welters, A., & Hempelmann, G. (1995). Thrombomodulin in intensive care patients. Intensive care medicine, 21(8), 645-50. https://doi.org/10.1007/BF01711542
Boldt, J, et al. "Thrombomodulin in intensive care patients." Intensive care medicine vol. 21,8 (1995): 645-50. doi: https://doi.org/10.1007/BF01711542
Boldt J, Wollbrück T, Sonneborn S, Welters A, Hempelmann G. Thrombomodulin in intensive care patients. Intensive Care Med. 1995 Aug;21(8):645-50. doi: 10.1007/BF01711542. PMID: 8522668.
Copy Download .nbib Format: NLM
Share it on

Intensive Care Med. 1995 Aug;21(8):645-50. doi: 10.1007/BF01711542.

Thrombomodulin in intensive care patients.

Intensive care medicine

J Boldt, T Wollbrück, S Sonneborn, A Welters, G Hempelmann

Affiliations

  1. Department of Anesthesiology and Intensive Care Medicine, Justus-Liebig-University, Giessen, Germany.

PMID: 8522668 DOI: 10.1007/BF01711542

Abstract

OBJECTIVE: Changes of endothelial-related coagulation was studied in intensive care patients.

DESIGN: Descriptive, prospective.

SETTING: Clinical investigation, intensive care unit of an university hospital.

PATIENTS: 40 consecutive critically ill patients with severe trauma (n = 20) or postoperative complications (n = 20) were studied. 14 patients suffered from sepsis, 12 patients suffered from acute renal failure.

INTERVENTIONS: 12 patients with acute renal failure were continuously hemofiltrated. All patients were on continuous sedation (fentanyl and midazolam) and mechanical ventilation.

MEASUREMENTS: In addition to standard coagulation variables, thrombomodulin (TM), protein C and protein S as well as thrombin/antithrombin III (TAT) plasma concentrations were measured from arterial blood samples using enzyme-linked immuno-sorbent assays (ELISA). Measurements were carried out on the day of admission (trauma patients) or on the day of diagnosis of sepsis and during the next 4 days.

MAIN RESULTS: Throughout the entire investigation period, TM plasma concentrations in patients with sepsis (baseline: 90 +/- 25 micrograms/l, 4th day: 152 +/- 28 micrograms/l) were significantly higher than in non-septic patients (baseline: 60 +/- 29 micrograms/l, 4th day: 42 +/- 15 micrograms/l). 15 of the 40 patients died within or after the end of the investigation period. TM plasma concentrations of survivors were lower (maximum: 63 +/- 18 micrograms/l) than in the non-survivors (maximum: 159 +/- 22 micrograms/l) (p < 0.05). Hemofiltered patients showed higher TM plasma levels, which further increased during the hemofiltration procedure. Protein C and (free) protein S were without significant group differences. TAT plasma levels were elevated above normal in all patients (no group differences).

CONCLUSIONS: Besides plasmatic and platelet-related coagulation, endothelium-associated coagulation appears to be also important for maintenance of hemostasis. TM plasma concentrations were elevated in all our critically ill patients, particularly when sepsis was evident. This appears to be most likely due to endothelial membrane damage with increased release of membrane-bound TM into the circulating blood in these patients. The importance of the elevated plasma levels of circulating soluble TM on hemostasis in these patients is an ongoing debate and warrants further studies.

References

  1. Blood. 1989 Jan;73(1):159-65 - PubMed
  2. Thromb Haemost. 1991 May 6;65(5):618-23 - PubMed
  3. Thromb Haemost. 1992 Oct 5;68(4):404-6 - PubMed
  4. J Clin Invest. 1990 Apr;85(4):1090-8 - PubMed
  5. Blood Coagul Fibrinolysis. 1992 Feb;3(1):113-7 - PubMed
  6. Blood. 1990 Nov 15;76(10):2024-9 - PubMed
  7. Thorac Cardiovasc Surg. 1991 Dec;39(6):338-43 - PubMed
  8. Prog Hematol. 1987;15:51-70 - PubMed
  9. Trends Cardiovasc Med. 1991 Dec;1(8):331-6 - PubMed
  10. Hosp Pract (Off Ed). 1992 Apr 15;27(4):145-50, 152, 163-6 - PubMed
  11. Proc Natl Acad Sci U S A. 1986 May;83(10):3460-4 - PubMed
  12. Chest. 1992 Jun;101(6):1644-55 - PubMed
  13. J Trauma. 1976 Nov;16(11):882-5 - PubMed
  14. Jpn Circ J. 1992 Feb;56(2):187-91 - PubMed
  15. Diabetes Care. 1991 Feb;14(2):160-6 - PubMed
  16. Chest. 1993 May;103(5):1536-42 - PubMed
  17. Am J Hematol. 1991 Dec;38(4):281-7 - PubMed
  18. J Cardiothorac Vasc Anesth. 1992 Dec;6(6):680-5 - PubMed
  19. Semin Hematol. 1992 Jul;29(3):213-26 - PubMed
  20. Blood. 1990 Jan 15;75(2):329-36 - PubMed
  21. J Clin Invest. 1985 Dec;76(6):2178-81 - PubMed
  22. Rinsho Byori. 1985 Oct;33(10):1113-8 - PubMed
  23. Blood. 1988 Mar;71(3):728-33 - PubMed
  24. Chest. 1992 Mar;101(3):594-6 - PubMed
  25. Nouv Rev Fr Hematol. 1991;33(6):529-30 - PubMed
  26. Annu Rev Med. 1990;41:15-24 - PubMed
  27. J Biol Chem. 1989 Mar 25;264(9):4743-6 - PubMed

Substances

MeSH terms

Publication Types